WAVERLEY PHARMA INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 5GZ for the last quarter is 33.31 k EUR, and it's 50.22% lower compared to the previous quarter. The net income of Q4 23 is -911.61 k EUR.